MichaelEdwinKafrissenMDMSPH

PubMed

• 42 citations
  Using self-reported data to assess the validity of driving simulation data.
  Bryan Reimer, Lisa A. D'Ambrosio, Joseph F. Coughlin, Michael E. Kafrissen, Joseph Biederman> ;Behavior Research Methods. 2006 May 1
• 10 citations
  Waiting for the second coming
  Jerome F. Strauss, Michael Kafrissen> ;Nature. 2004 Nov 4
• 15 citations
  Efficacy safety and cycle control of five oral contraceptive regimens containing norgestimate and ethinyl estradiol.
  Katherine D. LaGuardia, Gary A. Shangold, Alan C. Fisher, Andrew J. Friedman, Michael Kafrissen> ;Contraception. 2003 Jun 1
• 72 citations
  Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleeding.
  Ann J. Davis, Amy Godwin, Joel Lippman, William Olson, Michael E. Kafrissen> ;Obstetrics and Gynecology. 2000 Dec 1
• 149 citations
  Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial.
  Geoffrey P. Redmond, William Olson, Joel Lippman, M.S.P.H. Michael Edwin Kafrissen M.D., Terry M. Jones, Joseph L. Jorizzo> ;Obstetrics and Gynecology. 1997 Apr 1
• 19 citations
  A norgestimate-containing oral contraceptive: review of clinical studies.
  Michael E. Kafrissen> ;American Journal of Obstetrics and Gynecology. 1992 Oct 1
• 19 citations
  Review of the endometrial effects of estrogens and progestins.
  George W. Creasy, Michael E. Kafrissen, David Upmalis> ;Obstetrical & Gynecological Survey. 1992 Sep 1
• 24 citations
  Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: comparison with changes occurring during oral contraceptive therapy.
  Suzanne Lussier-Cacan, Marianne Xhignesse, Jean-Luc Desmarais, Jean Davignon, Michael E. Kafrissen, Alcide Chapdelaine> ;Metabolism. 1991 Aug 1
• 86 citations
  Endometrial morphology in asymptomatic postmenopausal women
  David F. Archer, Kathleen McIntyre-Seltman, Walter W. Wilborn, Edmond A. Dowling, Frederick Cone, George W. Creasy, Michael E. Kafrissen> ;American Journal of Obstetrics and Gynecology. 1991 Aug 1
• 52 citations
  Pharmacologic and pharmacokinetic characteristics of norgestimate and its metabolites
  J.L. McGuire, Audrey Phillips, Edward L. Tolman, Soledad Flor, Michael E. Kafrissen> ;American Journal of Obstetrics and Gynecology. 1990 Dec 1
• 1 citations
  Prevention of cardiovascular risk in women. A new concern for the obstetrician/gynecologist.
  Michael Edwin Kafrissen> ;Acta Obstetricia Et Gynecologica Scandinavica. Supplement. 1990 Jan 1
• 2 citations
  Cluster of abortion deaths at a single facility.
  Michael E. Kafrissen, David A. Grimes, Carol J. R. Hogue, Jeffrey J. Sacks> ;Obstetrics and Gynecology. 1986 Sep 1
• 35 citations
  Ectopic pregnancy mortality, United States, 1979 to 1980: clinical aspects.
  Dorfman Sf, David A. Grimes, Willard Cates, Nancy J. Binkin, Michael E. Kafrissen, O'Reilly Kr> ;Obstetrics and Gynecology. 1984 Sep 1
• 13 citations
  Coagulopathy and induced abortion methods: rates and relative risks.
  Michael E. Kafrissen, Morton W. Barke, Paul Workman, Kenneth F. Schulz, David A. Grimes> ;American Journal of Obstetrics and Gynecology. 1983 Oct 1
• 10 citations
  Abortion surveillance, 1979-1980.
  P R Lang, Nancy J. Binkin, Michael E. Kafrissen, Carol J. R. Hogue, E P Rhodenhiser, Hughes Jm, Jack C. Smith> ;MMWR. CDC Surveillance Summaries. 1983 May 1
• Norethindrone--a review of therapeutic applications.
  Taitel, H. F., Kafrissen, M. E.> ;Int J Fertil Menopausal Stud. 1995 Jul 01
• Metabolic effects and efficacy of a triphasic oral contraceptive (norgestimate/ethinyl estradiol).
  Andolsek, K. M., Burkman, R. T., Kafrissen, M. E., Olson, W., Osterman, J.> ;Int J Fertil Menopausal Stud. 1993
• Comparative review of third-generation progestins.
  Kafrissen, M. E., Corson, S. L.> ;Int J Fertil Menopausal Stud. 1993
• Midtrimester abortion. Intra-amniotic instillation of hyperosmolar urea and prostaglandin F2 alpha v dilatation and evacuation.
  Kafrissen, M. E., Schulz, K. F., Grimes, D. A., Cates, W.> ;JAMA. 1984 Feb 17
• Epidemic of gynecomastia among illegal Haitian entrants.
  Sattin, R. W., Roisin, A., Kafrissen, M. E., Dugan, J. B., Farer, L. S.> ;Public Health Rep. 1984 Sep 01
• Fatal hemorrhage from legal abortion in the United States.
  Grimes, D. A., Kafrissen, M. E., O'Reilly, K. R., Binkin, N. J.> ;Surg Gynecol Obstet. 1983 Nov
• Causes of maternal mortality in the United States.
  Kaunitz, A. M., Hughes, J. M., Grimes, D. A., Smith, J. C., Rochat, R. W., Kafrissen, M. E.> ;Obstet Gynecol. 1985 May 01
• Influence of a triphasic oral contraceptive preparation on plasma lipids and lipoproteins.
  Lussier-Cacan, S., Nestruck, A. C., Arslanian, H., Xhignesse, M., Davignon, J., Kafrissen, M. E., Chapdelaine, A.> ;Fertil Steril. 1990 Jan
• Comparative review of third-generation progestins.
  Kafrissen, M. E., Corson, S. L.> ;Int J Fertil. 1992
• Lipid and carbohydrate effects of a new triphasic oral contraceptive containing norgestimate.
  Burkman, R. T., Kafrissen, M. E., Olson, W., Osterman, J.> ;Acta Obstet Gynecol Scand Suppl. 1992
• Join now to see all